Showing results (1211-1220 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|October 17, 2021
Molecular imaging of cellular immunotherapies in experimental and therapeutic settingsNourhan Shalaby, Veronica Phyllis Dubois, John RonaldCancer Immunology, Immunotherapy : CII|February 8, 2022
GM-CSF elicits antibodies to tumor-associated proteins when used as a prostate cancer vaccine adjuvantHemanth K Potluri, Tun L Ng, Michael A Newton, et al.Cancer Immunology, Immunotherapy : CII|January 29, 2022
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progressionA Filippone, M Lanza, D Mannino, et al.Cancer Immunology, Immunotherapy : CII|January 30, 2022
Immune escape mechanism behind resistance to anti-PD-1 therapy in gastrointestinal tract metastasis in malignant melanoma patients with multiple metastasesMisato Ito, Kosaku Mimura, Shotaro Nakajima, et al.Cancer Immunology, Immunotherapy : CII|January 31, 2022
Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancerHong Kyu Lee, Hyeong-Jin Ji, Sang-Kyung Shin, et al.Cancer Immunology, Immunotherapy : CII|January 25, 2022
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidenceAnna Małgorzata Czarnecka, Paweł Sobczuk, Paweł Rogala, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2022
Altered immunity to microbiota, B cell activation and depleted γδ/resident memory T cells in colorectal cancerAlistair Noble, Edward T Pring, Lydia Durant, et al.Cancer Immunology, Immunotherapy : CII|April 21, 2022
Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancersHiroaki Wakiyama, Aki Furusawa, Ryuhei Okada, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2022
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacyYonggui Tian, Chunli Wen, Zhen Zhang, et al.Cancer Immunology, Immunotherapy : CII|April 18, 2022
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumabJamila Talb, Paul Takam Kamga, Marie Mayenga, et al.Pageof 651